Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Morphine sulphate suppositories
Moviprep		For radiology use
Mycophenolate		Specialist use only in neurological conditions
Mycophenolate mofetil injection	TA85 - Immunosuppressive therapy for renal transplantation in adults
Mycophenolate mofetil suspension	TA85 - Immunosuppressive therapy for renal transplantation in adults	New post-transplant
Mycophenolate mofetil tablets		New post transplant
Nab-paclitaxel
N-Acetylcysteine nebulised
Nalmefene	TA325 - Nalmefene for reducing alcohol consumption in people with alcohol dependence	Restricted to specialist substance misuse services
Naloxone injection

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.